Long-term care of the liver transplant recipient

Clinics in Liver Disease

Volumn 4, Issue 3, 2000, Pages 691-710

  Munoz, Santiago J ^a,c   Rothstein, Kenneth D ^a,c   Reich, David ^b,c   Manzarbeitia, Cosme ^b,c  

^a Carolinas Healthcare   (United States)

^b Liver Transplantation Program

^c ALBERT EINSTEIN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BONE DISEASE; DIABETES MELLITUS; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; KIDNEY DISEASE; LIVER FUNCTION; LIVER TRANSPLANTATION; OBESITY; PATIENT CARE; POSTOPERATIVE CARE; POSTOPERATIVE COMPLICATION; REVIEW; SURVIVAL;

EID: 0033892141     PISSN: 10893261     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1089-3261(05)70133-1     Document Type: Article

References (112)

1. L. Aronne Modern medical management of obesity: The role of pharmacological intervention J Am Diet Assoc 98 1998 523
2. B.A. Appignani R.A. Bhadelia S.C. Blacklow Neuroimaging findings in patients on immunosuppressive therapy: experience with tacrolimus toxicity Am J Rad 166 1996 683
3. American College of Physicians ed 3 1994 Guide for Adult Immunization Philadelphia
4. L. Beck S.P. Kumar Update in Preventive Medicine Ann Int Med 131 1999 681
5. T. Beresford Pschiatric follow up care of alcohol dependent liver graft recipients Lucey, Merion and Beresford: Liver Transplantation and the Alcoholic Patient 1994 Cambridge University Press
6. B.F. Boeve D.W. Kimmel A.E. Aronson Dysarthria and apraxia of speech Associated with FK506 (tacrolimus) Mayo Clin Proc 71 10 1996 969
7. D.J. Bronster S. Emre E. Mor Neurologic complications of orthotopic liver transplantation Mt Sinai J Med 61 1 1994 63
8. D.J. Bronster P. Boccagni M. O'Rourke Loss of speech after orthotopic liver transplantation Transpl Int 8 3 1995 234
9. G. Burbach U. Bienzle K. Stark Influenza vaccination in liver transplant recipients Transplantation 67 1999 753
10. D. Campbell M. Lucey Liver transplantation for alcoholic cirrhosis R. Busuttil G. Klintmalm Transplantation of the Liver 1996 WB Saunders Co Philadelphia 145 150
11. V.T. Canzanello L. Schwartz S.J. Taler Evolution of cardiovascular risk after liver transplantation: A comparison of cyclosporine A and tacrolimus (FK506) Liver Transpl Surg 3 1997 1
12. V.J. Canzanello S.C. Textor S.J. Taler Late hypertension after liver transplantation: A comparison of cyclosporine and tacrolimus (FK506) Liver Transpl Surg 4 1998 428
13. K.L. Carson C.M. Hunt Medical problems occurring after orthotopic liver transplantation Dig Dis Sci 42 8 1997 1666
14. G.W. Chapman J.B. Mailhes H.E. Thompson Morbidity in obese and nonobese patients following gynecologic surgery for cancer J Natl Med Assoc 80 1988 471
15. J.C. Coelho J.C. Wiederkehr R. Cat Extrapyramidal disorder secondary to cytomegalovirus infection and toxoplasmosis after liver transplantation Eur J Pediatr Surg 6 2 1996 110
16. K.L. Coffman A. Hoffman L. Sher Treatment of the postoperative alcoholic liver transplant recipient with other addictions Liver Transpl Surg 3 3 1997 322
17. M. Commander J. Neuberger C. Dean Psychiatric and social consequences of liver transplantation Transplantation 53 5 1995 1038
18. J.S. Crippin R.A. Jorgensen E.R. Dickson Hepatic osteodystrophy in primary biliary cirrhosis: The effects of estrogen administration Gastroenterology 102 1992 [abstract A 796]
19. M. Cvetkovic G.N. Mann D.F. Romero The deleterious effects of long-term cyclosporine A, cyclosporine G, and FK 506 on bone mineral metabolism in vivo Transplantation 57 1994 1231
20. T. Diamond D. Stiel S. Posen Osteoporosis in hemochromatosis: Iron excess, gonadal deficiency, or other factors? Ann Int Med 110 1989 430
21. T. Diamond D. Stiel M. Lunzer Ethanol reduces bone formation and may cause osteroporosis Am J Med 86 1989 282
22. R. Eastell E.R. Dickson S.F. Hodgson Rates of vertebral bone loss before and after liver transplantation in women with primary biliary cirrhosis Hepatology 14 1991 296
23. D.E. Eckhoff B.M. McGuire L.R. Frenette Tacrolimus (FK506) and mycophenolate mofetil combination therapy versus tacrolimus in adult liver transplantation Transplantation 65 1998 180
24. J. Everhart M. Lombardero J. Lake Weight change and obesity after liver transplantation: Incidence and risk factors Liver Transpl Surgery 4 1998 285
25. G.T. Everson T. Trouillot M. Wachs Early steroid withdrawal in liver transplantation is safe and beneficial Liver Transpl Surg 5 suppl 1999 S48
26. R.A. Fisher J.M. Ham A. Marcos A prospective randomized trial of mycophenolate mofetil with neoral or tacrolimus after orthotopic liver transplantation Transplantation 66 1998 1616 1621
27. T.A. Gonwa C.A. Morris R.M. Goldstein Long-term survival and renal function following liver transplantation in patients with and without hepatorenal syndrome experience in 300 patients Transplantation 51 1991 428
28. T.C. Gunning M.R. Brown T.H. Swygert Perioperative renal function in patients undergoing orthotopic liver transplantation. A randomized trial of the effects of verapamil Transplantation 51 1991 422
29. M. Guarino A. Stracciari P. Pazzaglia Neurological complications of liver transplantation J Neurol 243 2 1996 137
30. B.P. Garg L.E. Walsh M.D. Pescovitz Neurologic complications of pediatric liver transplantation Pediatr Neurol 9 6 1993 444
31. A. Grey K. Insogna Averting osteoporosis and its sequelae Contemporary Internal Medicine 9 1997 39
32. J.E. Hay E.R. Dickson R.H. Weisner Long-term effect of orthotopic liver transplantation on the osteopenia of primary biliary cirrhosis Hepatology 12 1990 838
33. J.E. Hay Bone disease after liver transplantation Liver Transpl Surg 1 1995 55
34. K. Hockerstedt S. Kajaste A. Muuronen Encephalopathy and neuropathy in end-stage liver disease before and after liver transplantation J Hepatol 16 1–2 1992 31
35. D. Hosking C.E.D. Chilvers C. Christiansen Prevention of bone loss with alendronate. In postmenopausal women under 60 years of age N Engl J Med 338 1998 485
36. D. Imagawa S. Dawson C. Holt Hyperlipidemia after liver transplantation: natural history and treatment with the hydroxymethylglutaryl-coenzyme A reductase inhibitor pravastatin Transplantation 62 1996 934
37. A.B. Jain R. Kashyap J. Rakela Primary adult liver transplantation under tacrolimus: More than 90 months actual follow-up survival and adverse events Liver Transpl Surg 5 1999 144 150
38. N.V. Jamieson Registry report on the results of combined liver/kidney transplantation for primary hyperoxaluria 1984–1994. European PH1 Transplantation Study Group Nephrol Dial Transplant 10 suppl 1995 33
39. D.R. Jeyarajah M. McBride G.B. Klintmalm Combined liver-kidney transplantation: What are the indications? Transplantation 64 1997 1091 1096
40. R.M. Jindal I. Popescu Renal dysfunction associated with liver transplantation Postgrad Med J 71 1995 513
41. R.J. Johnson D.R. Gretch H. Yamabe Membranoproliferative glomerulonephritis associated with hepatitis C virus infection N Engl J Med 328 1993 465 470
42. O. Jansen D. Krieger S. Krieger Cortical hyperintensity on proton density-weighted images: an MR sign of cyclosporine-related encephalopathy Am J Nucl Rad 17 2 1996 337
43. P.E. Kaplan D.M. Clinchot J.A. Arnett Cognitive deficits after hepatic transplantation: relevance to rehabilitation potential Brain Inj 10 8 1996 599
44. I.A. Katz M. Takizawa I.I. Joffe Comparison of the effects of FK 506 and cyclosporine on bone mineral metabolism in the rat Transplantation 52 1991 571
45. E.B. Keefe C. Gettys C.O. Esquivel Liver transplantation in patients with severe obesity Transplantation 57 1994 309
46. E.A. Kendrick J.P. McVicar K.V. Kowdley Renal disease in hepatitis C positive liver transplant recipients Transplantation 63 1997 1287
47. I. Kitai S. King A. Gafni An economic evaluation of varicella vaccine for pediatric liver and kidney recipients Clin Infect Dis 17 1993 441
48. 1 administration following orthotopic liver transplantation: A randomized prospective multicenter trial Gastroenterology 111 1996 710
49. J. Kobashigawa B. Kasiske Hyperlipidemia in solid organ transplantation Transplantation 63 1997 331
50. G. Lock A. Holstege A.R. Mueller Liver failure in erythropoietic protoporphyria associated with choledocholithiasis and severe post-transplantation polyneuropathy Liver 16 1996 211
51. M. Lucey Neurological and psychiatric complications associated with immunosuppression in liver transplantation Liver Transplant Surg 1 suppl 1 1995 39
52. B.P. Lukert L.G. Raisz Glucocorticoid-induced osteoporosis:pathogenesis and management Ann Intern Med 112 1990 352
53. 1) does not improve renal function in hepatic transplant recipients J Am Coll Surg 182 1996 347
54. D.J. Mazanec J.M. Grisanti Drug-induced osteoporosis Clev Clin J Med 56 1989 297
55. M. McClung B. Clemmesen A. Daifotis Alendronate prevents postmenopausal bone loss in women without osteoporosis: A double-blind, randomized, controlled trial Ann Int Med 128 1998 253
56. S.V. McDiarmid Renal function in pediatric liver transplant patients Kidney Int 49 suppl 1996 77
57. S.V. McDiarmid R.W. Busuttil P. Levy The long-term outcome of OKT3 compared with cyclosporine prophylaxis after liver transplantation Transplantation 52 1991 91
58. S.V. McDiarmid Mycophenolate mofetil in liver transplantation Clin Transplant 10 1996 140
59. H.P. Monsour Jr R.P. Wood C.H. Dyer Renal insufficiency and hypertension as long-term complications in liver transplantation Semin Liver Dis 15 1995 123
60. E. Moreno S.R. Gomez I. Gonzalez Neurologic complications in liver transplantation Acta Neurol Scand 87 1 1993 25
61. P.E. Morrissey F. Gordon D. Shaffer Combined liver-kidney transplantation in patients with cirrhosis and renal failure: Effect of a positive cross-match and benefits of combined transplantation Liver Transpl Surg 4 1998 363 369
62. C. Movsowitz S. Epstein M. Fallon Cyclosporine A in vivo produces osteopenia in the rat: Effect of dose and duration of administration Endocrinology 123 1988 2571
63. C. Movsowitz S. Epstein F. Ismail Cyclosporine A in the ophorectomized rat: Unexpected severe bone resorption J Bone Miner Res 4 1989 393
64. A.R. Mueller K.P. Platz W.O. Bechstein Neurotoxicity after orthotopic liver transplantation. A comparison between cyclosporine and FK506 Transplantation 58 2 1994 155
65. S.J. Munoz Long-term management of the liver transplant recipient Med Clin North Am 80 1996 1103
66. S.J. Munoz R.O. Deems M.J. Moritz Hyperlipidemia and obesity after orthotopic liver transplantation Transpl Proc 23 1991 1480
67. S. Munoz Progress in posttransplant hyperlipidemia [editorial] Liver Transpl Surg 3 1997 439
68. S. Munoz Hyperlipidemia and other coronary risk factors after orthotopic liver transplantation: pathogenesis, diagnosis and treatment Liver Transpl Surg 1 suppl 1 1995 29
69. R. Neuhaus A. Kubo R. Lohmann Calcitriol in prevention and therapy of osteoporosis after liver transplantation Transplant Proc 31 1999 472
70. R. Neuhaus R. Lohmann K.P. Platz Treatment of osteoporosis after liver transplant Transpl Proc 27 1995 1226
71. M. Palmer F. Schaffner S.N. Thung Excessive weight gain after liver transplantation Transplantation 51 1991 797
72. L.B. Pemberton W.G. Manal Relationship of obesity to postoperative complications after cholecystectomy Am J Surg 121 1971 87
73. M.D. Porayko R.H. Weisner J.E. Hay Bone disease in liver transplant recipients: Incidence, timing and risk factors Transpl Proc 23 1991 1462
74. R.W. Postlethwait W.D. Johnson Complications following surgery for duodenal ulcer in obese patients Arch Surg 105 1972 438
75. C. Power S.D. Poland K.H. Kassim Encephalopathy in liver transplantation: neuropathology and CMV infection Can J Neurol Sci 17 4 1990 378
76. J. Pratschke R. Neuhaus S.G. Tullius Treatment of cyclosporine-related adverse events by conversion to tacrolimus after liver transplantation Transplantation 64 6 1997 938
77. A. Pujol F. Graus A. Rimola Predictive factors of in-hospital CNS complications following liver transplantation Neurology 44 7 1994 1226
78. A. Rasmussen H.S. Davies N.V. Jamieson Combined transplantation of liver and kidney from the same donor protects the kidney from rejection and improves kidney graft survival Transplantation 59 1995 919 921
79. H. Reeves R. Francis D. Manas Intravenous diphosphonates prevents symptomatic vertebral collapse in patients after liver transplantation Liver Transpl Surg 4 1998 404
80. D. Reich K. Rothstein C. Manzarbeitia Common medical diseases after liver transplantation Semin Gastrointest Dis 9 1998 110 125
81. P.L. Robertson K.M. Muraszko R.A. Axtell Hepatoblastoma metastatic to brain: prolonged survival after multiple surgical resections of a solitary brain lesion J Pediatr Hematol Oncol 19 2 1997 168
82. H. Roggla G. Roggla F. Muhlbacher Psychiatric prognostic factors in patients with alcohol-related end-stage liver disease before liver transplantation Wien Klin Wochenschr 108 9 1996 272
83. W.J. Sandborn J.E. Hay M.K. Porayko Cyclosporine withdrawal for nephrotoxicity in liver transplant recipients does not result in sustained improvement in kidney function and causes cellular and ductopenic rejection Hepatology 19 1994 925
84. R. Sawyer S. Pelletier T. Pruett Increased early mortality and morbidity with acceptable long term function in severely obese patients undergoing liver transplantation Clin Transplant 13 1999 126
85. A.J. Schreiber F.R. Simon Estrogen-induced cholestasis: Clue to pathogenesis and treatment Hepatology 3 1983 607
86. M. Schlosberg C. Moskowitz S. Epstein The effect of cyclosporine A administration and its withdrawal on bone mineral metabolism in the rat Endocrinology 124 1989 2179
87. P. Seu A.H. Wilkinson A. Shaked The hepatorenal syndrome in liver transplant recipients Am Surg 57 1991 806
88. N. Singh V.L. Yu T. Gayowski Central nervous system lesions in adult liver transplant recipients: clinical review with implications for management Medicine (Baltimore) 73 2 1994 110
89. M. Stegall G. Everson G. Schroter Metabolic complications after liver transplantation: diabetes, hypercholesterolemia, hypertension and obesity Transplantation 60 1995 1057
90. M. Stegall M. Wachs G. Everson Prednisone withdrawal 14 days after liver transplantation with mycophenolate: A prospective trial of cyclosporine and tacrolimus Transplantation 64 1997 1755
91. A.J. Stellon A. Webb J.E. Compston Bone histomorphometry and structure in corticosteroid treated chronic active hepatitis Gut 29 1988 378
92. A.J. Stellon A. Davies J. Compston Bone loss in autoimmune chronic active hepatitis on maintenance corticosteroid therapy Gastroenterol 89 1985 1078
93. K. Swenson P. Seu M. Kinkhabwala Liver transplantation for adult polycystic liver disease Hepatology 28 1998 412 415
94. The U. S. Multicenter FK506 Liver Study Group A comparison of tacrolimus (FK506 and cyclosporine for immunosuppression in liver transplantation N Engl J Med 331 1994 1110
95. K.C. Trail R.J. Stratta J.L. Larsen Orthotopic hepatic transplantation in patients with type I diabetes mellitus J Am Coll Surg 178 1994 337
96. S.C. Textor R. Wiesner D.J. Wilson Systemic and renal hemodynamic differences between FK506 and cyclosporine in liver transplant recipients Transplantation 55 1993 1332
97. J. Torre-Cisneros O.L. Lopez S. Kusne CNS aspergillosis in organ transplantation: A clinicopathological study J Neurol Neurosurg Psychiatry 56 1993 188
98. K.C. Trail R.J. Stratta J.L. Larsen Results of liver transplantation in diabetic recipients Surgery 114 1993 650
99. R.A. Tringali P.T. Trzepacz A. Dimartini Assessment and follow-up of alcohol-dependent liver transplantation patients. A clinical cohort Gen Hosp Psychiatry 18 6 suppl 1996 70S
100. F. Valldeoriola F. Graus A. Rimola Cyclosporine-associated mutism in liver transplant patients Neurology 46 1 1996 252
101. M.A. Valero C. Loinaz L. Larrodera Calcitonin and biphosphonates treatment in bone loss after transplantation Calcif Tissue Int 57 1995 15
102. E. Vieta J. De Pablo E. Cirera Postoperative psychiatric complications following liver transplantation Med Clin (Barc) 100 6 1993 210
103. M. Walser H.H. Drew N.D. LaFrance Creatinine measurements often yielded false estimates of progression in chronic renal failure Kidney Int 34 1988 412
104. W.K. Washburn L.B. Johnson W.D. Lewis Liver transplantation for adult polycystic liver disease Liver Transpl Surg 2 1996 17
105. C.J.E. Watson P.J. Friend N.V. Jamieson Sirolimus: A potent new immunosuppressant for liver transplantation Transplantation 67 1999 505 509
106. R.H. Wiesner R.M. Goldstein J.P. Donovan The impact of cyclosporine dose and level on acute rejection and patient and graft survival in liver transplant recipients Liver Transpl Surg 4 1998 34
107. E.F. Wijdicks D.J. Plevak R.H. Wiesner Causes and outcome of seizures in liver transplant recipients Neurology 47 6 1996 1523
108. E.F. Wijdicks R.H. Wiesner R.A. Krom Neurotoxicity in liver transplant recipients with cyclosporine immunosuppression Neurology 45 11 1995 1962
109. A.H. Wilkinson T.A. Gonwa D.A. Distant Renal failure in the adult liver transplant recipient R.W. Busuttil G.B. Klintmalm Transplantation of the Liver 1996 WB Saunders Philadelphia 588 595
110. M. Winkler G. Haller K. Oldhafer A new oral formulation of cyclosporine for early oral immunosuppressive therapy in liver transplant recipients Transplantation 62 1996 1063
111. Z.K. Wszolek R.E. Steg Seizures after orthotopic liver transplantation Seizure 6 1 1997 31
112. W.T. Yuh T.M. Simonson M.P. D'Alessandro Temporal changes of MR findings in central pontine myelinolysis Am J Nucl Rad 16 4 suppl 1995 975